alexa Synergism Of ?nutraceutical? And ?pharmaceutical? For Safety | 22463
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference and Exhibition on Biowaivers, Biologics & Biosimilars

Ekta K Kalra
ScientificTracks Abstracts: J Bioanal Biomed
DOI: 10.4172/1948-593X.S1.013
Abstract
Combination therapy and synergism of ?Nutraceutical? and ?Pharmaceutical? can be recommended for safety, reduction of adverse effects, reduction of interactions and improvement of quality of healthcare services. For instance, Withania somnifera is the medicinal plant with proven anti-diabetic effect and used in the treatment of diabetes. It can therefore be suggested to prescribe Withania somnifera (May be Less Side Effects) with the required pharmaceutical medicine (May be More Side Effects). A combination therapy can thus help pharmaceuticals gain the image of lesser side effects and as they being respectful of natural products. It is recommended to prescribe the natural with the synthetic to make the best of health care approach. For instance, if a pharmaceutical medicine has a dose of 100 mg then the dose can be reduced to 70 mg by prescribing it with a natural medicine. Cod liver oil which is a nutraceutical and has antidepressant effect can be prescribed with amitriptyline hydrochloride (Allopathic medicine) or imipramine (Allopathic medicine). However, it is important to study the pharmaceutical and nutraceutical drug interaction before prescribing a combination of any two products together. Certain symptoms of a disease might be difficult to treat with one medicine in allopathic method of treatment. If some symptoms of a disease can be treated better with allopathic medicines and some symptoms with nutraceutical then a combination therapy be used. In another example the therapeutic drug can be a pharmaceutical but it can be combined with nutraceuticals where the natural products help fight the side effects of the pharmaceuticals. In such cases the main medicine can be an allopathic drug and the side effect of this drug can be treated with a nutraceutical. Another important aspect that can be considered in Nutraceutical research is: learning from Ayurveda , Chinese medicines, Herbal medicines, etc. so that knowledge does not repeat itself by human intelligence. If a person wants to make a selection between nutraceutical and pharmaceutical for the treatment of a disease then the patient should have the free will to do so. This will enable better compliance of patients especially in case of psychiatric disorders treatment. However, the free will to choose between nutraceutical and pharmaceutical should not be granted in case of serious illnesses or where the two types of therapies are not almost equally effective for a disease. The same free will can be exercised when a patient wants to choose whether the side effects of an allopathic medicine are to be treated by a pharmaceutical or a nutraceutical. This can be considered as an advanced treatment method where the physician and the pharmacist should be trained in two human well being granting therapeutic methods. Another option can be that the people who treat using Nutraceuticals can be called ?Nutracists? and the expertise in this area can be added to Pharmacists qualification by doing some certificate courses. The major regulatory problem that can be considered in case of Nutraceutical is its ?Effectiveness?. The ?Safety? of Nutraceuticals can be almost assured. The major regulatory problem that can be considered in case of Biosimilars is its ?Safety?. The ?Effectiveness?of Biosimilars can be almost assured. It can be recommended that for regulatory purpose the Biosimilars and Nutraceuticals should be compared with each other so that there is comparison of the best in the market. Don?t be afraid of the safety of Nutraceuticals and don?t let Nutraceuticals be afraid of Biosimilars! Give the Patient World?s Best Choice NOT Just a Choice!
Biography
Ekta K Kalra has completed her Masters in Pharmaceutical Sciences from Nagpur University, India. She is the sole author of the globally recognized publication on Nutraceutical (Kalra EK. Nutraceutical-definition and introduction. AAPS PharmSci. 2003; 5(3):E25). She is working as a Freelance writer.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

eng[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7